Histologic reporting of malignant melanoma

Area of Science:

• Dermatopathology
• Oncology
• Histologic Reporting Standards

Background:

• Current histologic reporting for malignant melanoma lacks comprehensive standardization.
• Several prognostic variables, such as tumor pigmentation and S-100 protein immunoreactivity, are not consistently addressed.
• Emerging genomic data may reveal additional prognostic histological parameters.

Purpose of the Study:

• To establish a uniform and comprehensive schema for histologic reporting of malignant melanoma.
• To integrate diagnostic criteria with prognostic indicators for improved patient management.
• To create a foundational database for future research on melanoma prognosis.

Main Methods:

• Implementation of a three-tiered reporting system for malignant melanoma.
• Tier 1: Establishment of diagnosis, assessment of dermal invasion (vertical growth phase in millimeters), and optional radial growth phase subclassification.
• Tier 2: Inclusion of subsidiary diagnostic statements (e.g., ulceration, mitotic activity, vascular invasion, satellites, host response, regression, associated pathology). Tier 3: Optional narrative statements for additional descriptors (e.g., S-100 immunoreactivity).

Main Results:

• The proposed schema provides a structured approach to malignant melanoma histologic reporting.
• It incorporates essential diagnostic information and prognostic parameters.
• The system allows for the inclusion of optional and future-relevant histological details.

Conclusions:

• The recommended histologic reporting schema enhances diagnostic consistency for malignant melanoma.
• It integrates critical prognostic factors, aiding in patient outcome prediction.
• The framework supports the prospective collection of data for advancing melanoma research and identifying new prognostic markers.